Amicus Therapeutics Inc (MEX:FOLD)
MXN 208.8 0 (0%) Market Cap: 60.68 Bil Enterprise Value: 64.66 Bil PE Ratio: 0 PB Ratio: 16.63 GF Score: 78/100

Amicus Therapeutics Inc at Citi BioPharma Conference (Virtual) Transcript

Sep 10, 2020 / 12:55PM GMT
Release Date Price: MXN315.03
Mohit Bansal
Citigroup Inc., Research Division - Director and Analyst

Okay, great. Thank you very much. So thank you, everyone, for joining us today. My name is Mohit Bansal. I'm one of the Biotech Analysts here at Citi. And I'm happy to have the Amicus management team with us today. We have John Crowley, the Chairman and CEO of the company; Daphne Quimi, the CFO of the company; and Hung Do, the Chief Scientific Officer of the company. We are also joined by Andrew from the IR team as well. Thank you, John, for joining us today.

John F. Crowley
Amicus Therapeutics, Inc. - Chairman & CEO

Yes. Good morning, everybody. Thanks, Mohit.

Questions & Answers

Mohit Bansal
Citigroup Inc., Research Division - Director and Analyst

Great. So before we start, if you have any questions on the call, feel free to e-mail me. And also on this webcast, there is a mechanism where you can actually submit your question and you come directly in my inbox, and I'll be happy to take that question anonymously for you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot